Dermal hyperpigmentation: pathogenesis, biomarkers and translational safety considerations for emerging therapies

Cutaneous and Ocular Toxicology · Published 2026-08-05 · DOI 10.1080/15569527.2026.2711637

Authors (3)

S. Ruchitha, Yashodhara Dalal, Kavita Singh

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ruchitha, S., Dalal, Y., Singh, K. (2026). Dermal hyperpigmentation: pathogenesis, biomarkers and translational safety considerations for emerging therapies. Cutaneous and Ocular Toxicology. https://doi.org/10.1080/15569527.2026.2711637

Related articles